In the BioHarmony Drug Report Database

"Preview" Icon

Inclisiran

Leqvio (inclisiran) is an oligonucleotide pharmaceutical. Inclisiran was first approved as Leqvio on 2020-12-09. It has been approved in Europe to treat dyslipidemias and hypercholesterolemia.

 

Trade Name

 

Leqvio
 

Common Name

 

inclisiran
 

ChEMBL ID

 

CHEMBL3990033
 

Indication

 

dyslipidemias, hypercholesterolemia
 

Drug Class

 

Image (chem structure or protein)

Inclisiran structure rendering